Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer.
Kuo-Hsing ChenChia-Lang HsuYu-Li SuChang-Tsu YuanLiang-In LinJia-Huei TsaiYi-Hsin LiangAnn-Lii ChengKun-Huei YehPublished in: British journal of cancer (2022)
Complement activation in the TME was significantly associated with poor OS and was correlated with TAM M2 in patients with de novo metastatic BRAF V600E mutant CRC.